Evidence map›Paper›PMID 26481500›Full record

ReviewTrends in biochemical sciences2015

Chemistry and Biology of Self-Cleaving Ribozymes.

Randi M Jimenez, Julio A Polanco, Andrej Lupták

Abstract readReview
In one paragraph

Review in Trends in biochemical sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 188 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. From Catalysis of Evolution to Evolution of Catalysis.Accounts of chemical research · 2024
    Article
  12. Article
  13. Article
  14. Genetic disruption of the bacterialProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  15. Inhibition ofeLife · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Randi M JimenezDepartment of Molecular Biology and Biochemistry, University of California, Irvine, CA, USA.
Julio A PolancoDepartment of Molecular Biology and Biochemistry, University of California, Irvine, CA, USA.
Andrej LuptákDepartment of Molecular Biology and Biochemistry, University of California, Irvine, CA, USA; Department of Pharmaceutical Sciences, University of California, Irvine, CA, USA; Department of Chemistry, University of California, Irvine, CA, USA. Electronic address: aluptak@uci.edu.
University of California, Irvine · US

Funding

Discovery and characterization of self-cleaving ribozyme structural variantsF31GM103241 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI JIMENEZ, RANDI · 2013 to 2014
$72k
NIGMS NIH HHS F31 GM103241
6 · The paper itself

Abstract

Self-cleaving ribozymes were discovered 30 years ago, but their biological distribution and catalytic mechanisms are only beginning to be defined. Each ribozyme family is defined by a distinct structure, with unique active sites accelerating the same transesterification reaction across the families. Biochemical studies show that general acid-base catalysis is the most common mechanism of self-cleavage, but metal ions and metabolites can be used as cofactors. Ribozymes have been discovered in highly diverse genomic contexts throughout nature, from viroids to vertebrates. Their biological roles include self-scission during rolling-circle replication of RNA genomes, co-transcriptional processing of retrotransposons, and metabolite-dependent gene expression regulation in bacteria. Other examples, including highly conserved mammalian ribozymes, suggest that many new biological roles are yet to be discovered.

Indexed as

AnimalsHydrolysisRNA, CatalyticRNA, Catalyticaptazymesretrotransposonriboregulationriboswitchribozymeself-scission

Identifiers

PMID26481500
PMCPMC4630146
OpenAlexW2167470206

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.